business as explained earlier as well as the planned turnaround at the PET location in China. Strength in secondary feed- stocks like IPA which benefitted IVL in the EMEA region impacted the PET business
EBITDA and ROCE were weak for the quarter and LTM due to de-consolidation of India PET business as explained earlier. Earn- ings were also impacted due to the planned maintenance shutdown at the PET
strong underlying performance as explained earlier. Figure 1: Core EBITDA Evolution V Note: Total of all regions may not match to IVL due to holding segment. Indorama Ventures 3rd Quarter 2018 MD&A 7
decline from 31.3 % in Q1/2017 as a result of higher cost of goods sold as earlier explained. 45% 45% 49% 45% 48% 55% 55% 51% 55% 52% 25% 30% 35% 40% 45% 50% 55% 60% Q1/17 Q2/17 Q3/17 Q4/17 Q1/18 Brand
be explained together with name list of other shareholding. The explanation, i.e., shareholding percentage and structure, other shareholders names, etc. (if possible) shall be provided to the SEC
Section 258, for example multiple levels of shareholding structure, structure and proportion of shareholding shall be explained together with name list of other shareholding. The explanation, i.e
or concert party in a juristic person under Section 258, for example multiple levels of shareholding structure, structure and proportion of shareholding shall be explained together with name list of
shareholding structure of the reporter or concert party in a juristic person under Section 258, for example multiple levels of shareholding structure, structure and proportion of shareholding shall be explained